全文获取类型
收费全文 | 23739篇 |
免费 | 1658篇 |
国内免费 | 671篇 |
专业分类
耳鼻咽喉 | 218篇 |
儿科学 | 311篇 |
妇产科学 | 274篇 |
基础医学 | 1114篇 |
口腔科学 | 286篇 |
临床医学 | 2862篇 |
内科学 | 4559篇 |
皮肤病学 | 117篇 |
神经病学 | 602篇 |
特种医学 | 694篇 |
外国民族医学 | 1篇 |
外科学 | 3801篇 |
综合类 | 4789篇 |
现状与发展 | 4篇 |
预防医学 | 971篇 |
眼科学 | 1438篇 |
药学 | 1879篇 |
28篇 | |
中国医学 | 1618篇 |
肿瘤学 | 502篇 |
出版年
2024年 | 47篇 |
2023年 | 354篇 |
2022年 | 685篇 |
2021年 | 1161篇 |
2020年 | 899篇 |
2019年 | 766篇 |
2018年 | 753篇 |
2017年 | 761篇 |
2016年 | 797篇 |
2015年 | 886篇 |
2014年 | 1795篇 |
2013年 | 1552篇 |
2012年 | 1658篇 |
2011年 | 1740篇 |
2010年 | 1354篇 |
2009年 | 1337篇 |
2008年 | 1318篇 |
2007年 | 1225篇 |
2006年 | 1161篇 |
2005年 | 998篇 |
2004年 | 723篇 |
2003年 | 595篇 |
2002年 | 502篇 |
2001年 | 434篇 |
2000年 | 329篇 |
1999年 | 269篇 |
1998年 | 216篇 |
1997年 | 207篇 |
1996年 | 168篇 |
1995年 | 180篇 |
1994年 | 159篇 |
1993年 | 146篇 |
1992年 | 108篇 |
1991年 | 64篇 |
1990年 | 93篇 |
1989年 | 70篇 |
1988年 | 83篇 |
1987年 | 60篇 |
1986年 | 61篇 |
1985年 | 64篇 |
1984年 | 55篇 |
1983年 | 30篇 |
1982年 | 41篇 |
1981年 | 22篇 |
1980年 | 23篇 |
1979年 | 24篇 |
1978年 | 22篇 |
1977年 | 14篇 |
1976年 | 12篇 |
1973年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
141.
p38丝裂原活化蛋白激酶在糖尿病大鼠神经病理性痛中的作用 总被引:1,自引:0,他引:1
目的探讨p38丝裂原活化蛋白激酶(p38MAPK)在链脲菌素诱导的糖尿病大鼠神经病理性痛中的作用。方法雌性Wistar大鼠31只,3月龄,体重180~220g,随机分为3组:对照组(C组,n=10)、糖尿病神经病理性痛组(D组,n=11)和p38MAPK抑制剂组(Ⅰ组,n=10)。D组、Ⅰ组单次腹腔注射链脲菌素65mg/kg制备糖尿病模型。糖尿病模型制备成功后,Ⅰ组尾静脉注射p38MAPK抑制剂SB203580 0.5mg/kg,1次/周,连续4周;C组和D组尾静脉注射等体积的生理盐水。给药4周后,测定机械缩足反应阈值(MWT)、左侧坐骨神经传导速率(NCV)、背根神经节(DRG)和脊髓的磷酸化p38MAPK水平。结果与C组比较,D组、Ⅰ组MWT下降,NCV减慢,伴有脱髓鞘现象,DRG和脊髓的磷酸化p38MAPK水平升高;与D组比较,Ⅰ组MWT升高,NCV增快,脱髓鞘程度减轻,DRG和脊髓的磷酸化p38MAPK水平下降。结论p38MAPK信号转导通路参与了糖尿病大鼠神经病理性痛的形成。 相似文献
142.
143.
Acute colonic pseudo-obstruction (ACPO), also known as Ogilvie’s syndrome, is a rare condition associated with massive dilatation
of the colon in the absence of any mechanical obstruction. Between 4 and 35% of all reported cases of ACPO have occurred in
association with pregnancy or puerperium, with most of these occurring after caesarean sections. We present a case report
of the successful management of a patient with ACPO. 相似文献
144.
145.
This study was designed to investigate the effect of morphine on formalin-induced nociceptive responses in streptozotocin (STZ) induced-diabetic mice, noninsulin-dependent genetically diabetic db/db mice and their respective controls (ddY and +/+). In nondiabetic (ddY and +/+) mice, morphine (1–10 mg/kg, PO) dose dependently attenuated the biphasic nociceptive responses induced by SC injection of formalin to the hindpaw, demonstrating equipotency on both the first and second phases. Para-chlorophenylalanine (800 mg/kg × 2, PO) and pindolol (1 mg/kg, IP) reduced the effect of morphine on the first phase, sulpiride (10 mg/kg, IP) abolished the effect on both phases, while ketanserin (1 mg/kg, IP) had no effect. In STZ (200 mg/kg, IP)-diabetic mice, morphine weakly attenuated the nociception in comparison to control ddY mice, whereas it had comparable effects in both the first and second phases of control +/+ mice and db/db mice. The serotonergic agonist, meta-chlorophenylpiperazine (0.32–3.2 mg/kg, PO), dose dependently attenuated the biphasic nociceptive responses to formalin in both phases of diabetic mice; however, FR64822, a dopaminergic compound (0.1–10 mg/kg, PO), had little effect. We speculate that activation of both dopaminergic (DA)- and serotonergic-mediated mechanisms are potentially responsible for the effect of morphine on the first phase, while the DA-mediated effect is involved in the second phase. The DA-mediated mechanism, but not the serotonin-mediated one, appears to be altered in both STZ-diabetic and db/db mice. These results suggest that the attenuated effects of morphine might be due to a dopaminergic dysfunction in STZ mice, and that there might be other mechanisms compensating for this attenuation of dopaminergic function in db/db mice. 相似文献
146.
M. J. Stevens D.E. Goss A.V.M. Foster D. Pitei M.E. Edmonds P.J. Watkins 《Diabetic medicine》1993,10(10):909-915
The diabetic neuropathic ulcer is typically slow to heal and recurrent. Macrovascular insufficiency is usually excluded as foot pulses are present and ankle:brachial pressure ratios are not decreased. These assessments cannot however exclude more distal vascular disease. Digital pressure measurements enable a reliable assessment of the distal peripheral vascular status to be made. The aim of this study was therefore to use toe pressures to assess the contribution of distal ischaemia in the pathogenesis of the neuropathic ulcer. Sixteen diabetic patients with recurrent neuropathic foot ulceration had their toe pressures compared to 10 neuropathic patients without a history of foot ulceration, 10 diabetic control subjects, and 11 normal subjects. Four non-diabetic patients with neuropathy and foot ulceration were also assessed. All subjects had ankle:brachial pressure indices ≧ 1. Toe pressure was assessed using laser Doppler flowmetry to record the return of skin blood flow. The toe:brachial pressure index (TBI) was then calculated. The diabetic patients with a history of recurrent neuropathic ulceration, had the lowest mean TBI, 0.63 ± 0.14 (SD), compared to the non-ulcerated diabetic neuropathy patients, the diabetic control subjects, and the normal subjects. 0.84 ± 0.11, 0.82 ± 0.1, and 0.81 ± 0.07, p < 0.01, respectively. Three of the four non-diabetic patients with neuropathic foot ulceration also had an abnormally low TBI. Reduced toe pressure measurements are thus found to be associated with neuropathic foot ulceration. The contribution of distal ischaemia in the pathogenesis of the diabetic neuropathic foot ulcer needs to be evaluated. One hundred and eight non-insulin-dependent diabetic patients who had been tested for autonomic dysfunction in 1984/85 were re-evaluated 5 years later. Autonomic function was assessed by means of four cardiovascular tests (heart rate variation during deep breathing and standing, and blood pressure variation after standing and sustained handgrip). Eighteen subjects were lost to follow-up; in the 90 patients who completed the study, both the deep breathing and the handgrip test significantly worsened (respectively from 13.7 ± 7.8 to 11.6 ± 6.3 beats min?1 p < 0.01, and from 16.9 ± 8.2 to 12.7 ± 7.1 mmHg, p < 0.001), whereas both the 30:15 ratio and the variation of blood pressure on standing did not change. The impairment of a comprehensive evaluation score (from 2.5 ± 1.7 to 3.0 ± 1.5; p < 0.05) also confirmed the gradual deterioration of autonomic function over the study period. 相似文献
147.
148.
背景 近年来,人工智能(AI)在医学领域发展迅速,在糖尿病视网膜病变(DR)中的应用范围不断扩展。目的 通过文献计量分析总结AI在DR领域的应用情况,阐明AI在DR领域相关研究的现状、热点和新兴趋势,以期为未来的研究提供思路。方法 以Web of Science数据库为来源,检索建库至2022-11-04的AI应用于DR领域的相关文献,运用CiteSpace软件对纳入文献进行发文量、国家、机构、作者、共被引和关键词的文献计量学分析。结果共获得1 770篇文献,2011年1月至2022年11月发文量总体呈上升趋势,2021年发文量达峰值(402篇)。中国是发文量(440篇)位居第1的国家,英国为中心性(0.26)最高的国家。机构合作网络图谱共纳入436家机构,以中山大学和首都医科大学为代表。作者合作网络图谱共纳入601位作者,以JIA Y L和HWANG T为代表。GULSHAN V、ABRàMOFF M D与TING D W 3位高被引作者对该领域做出了重要贡献。Ophthalmology、Invest Ophth Vis Sci和Ieee T Med Imaging是AI应用于DR领... 相似文献
149.
150.
Microalbuminuria is a predictor of renal and cardiovascular disease in both type 1 (insulin-dependent) and type 2 (insulin-independent) diabetes. We report on a screening programme for microalbuminuria at a diabetes clinic in Italy. All diabetic patients without Albustix-positive proteinuria attending the clinic between April and September 1991 were screened. Microalbuminuria was defined as a urinary albumin/creatinine ratio, on an early morning sterile urine sample, >3 in at least two consecutive urine collections. Three hundred and fifty patients, 45 (20 female, 25 female) type 1 and 305 (145 male, 160 female) type 2 diabetics, were examined. The age range was 18–42 years and 36–73 years and duration of diabetes 1–24 and 1–35 years for type 1 and type 2 diabetic patients respectively. Blood pressure, lipids, glycosylated haemoglobin, body mass index and insulin dose, where appropriate, were measured in all patients. Microalbuminuria was found in 8 (22%) of the type 1 diabetics. These patients had a longer duration of diabetes (17.5 vs 7.4 years,P<0.001), higher diastolic blood pressure (86±2.1 vs 76±2.6 mmHg,P<0.05) and an increased total serum cholesterol level (203±23 vs 180±25 mg/dl,P<0.05) compared with diabetic patients with microalbuminuria. Of the type 2 diabetic patients 95 (33%) were found to have microalbuminuria and 210 (69%) nor-moalbumiuria. The prevalence of hypertension (defined blood pressure >140/90 mmHg or antihypertensive treatment) and of dyslipidaemia (defined as total cholesterol >200 and triglycerides >170 or hypolipidaemic treatment) were significantly higher (P<0.001 and 0.01 respectively) in patients with microalbuminuria. This study shows a prevalence of microalbuminuria in type 1 and type 2 diabetic patients similar to that reported in surveys of diabetes clinic outpatients in northern Europe. The association between microalbuminuria and recognized risk factors for cardiovascular and renal disease justifies screening programmes for microalbuminuria for early detection of at-risk diabetic patients and for the implementation of preventive therapeutic measures. 相似文献